Mesenchymal stem cells (MSC) may transdifferentiate into neural cells in vitro under the influence of matrix molecules and growth factors present in neurogenic niches. However, further experiments on the behavior of such stem cells remain to be done in vivo. In this study, rat MSC (rMSC) have been grafted in a neurogenic environment of the rat brain, the subventricular zone (SVZ), in order to detect and follow their migration using superparamagnetic iron oxide (SPIO) nanoparticles. We sought to characterize the potential effect of iron loading on the behavior of rMSC as well as to address the potential of rMSC to migrate when exposed to the adequate brain microenvironment. 1-hydroxyethylidene-1.1-bisphosphonic acid (HEDP)-coated SPIO nanoparticles efficiently labeled rMSC without significant adverse effects on cell viability and on the in vitro differentiation potential. In opposition to iron-labeled rat neural stem cells (rNSC), used as a positive control, iron-labeled rMSC did not respond to the SVZ microenvironment in vivo and did not migrate, unless a mechanical lesion of the olfactory bulb was performed. This confirmed the known potential of iron-labeled rMSC to migrate toward lesions and, as far as we know, this is the first study describing such a long distance migration from the SVZ toward the olfactory bulb through the rostral migratory stream (RMS).
INTRODUCTION
Stem cells are often described as the best candidates for cell therapy studies due to their selfrenewal capacity and their large differentiation potential. Among them, mesenchymal stem cells (MSC) remain easy to isolate and expand. They may exhibit immunodepressive characteristics which make them less sensitive to rejection by the host immune system [25, 30, 34] . Moreover, MSC allow autologous grafts to be performed in cell therapy protocols. Bone marrow MSC typically differentiate into connective tissue cell types [12, 21] , but various laboratories have also reported the transdifferentiation potential of MSC into a neuronal-like phenotype [5, 39, 46] . We previously showed that a subpopulation of human MSC, marrow-isolated adult multilineage inducible (MIAMI) cells may trandifferentiate in vitro in a neurotrophin-dependent manner into neuronal-like cells. These cells express neuronal markers and present electrophysiological characteristics similar to those observed in mature neurons [44] . Moreover, a fraction of MSC transplanted in adult rat brains may respond to microenvironmental cues and transdifferentiate into neuronal-like cells [20, 23, 52] . Using different brain lesion models, it has been shown that implanted MSC may be involved in functional improvement, either directly or indirectly by their ability to produce various growth factors [9, 27, 28, 51] . In addition, a damaged environment resulting e.g. from ischemia or from the presence of a tumor is known to stimulate the migration of transplanted MSC [20, 28, 41] as well as of neuronal precursors [1, 22] . MSC may thus be considered as potential candidates for cell therapy studies in the central nervous system. However, the possible use of MSC for brain repair studies still requires an evaluation of their behavior, migratory dynamic and fate in vivo. Moreover, as only a fraction of the transplanted cells may respond to the stimuli of the microenvironment, highly sensitive procedures will be required in the future.
Magnetic resonance imaging (MRI) is a non-invasive tool that has demonstrated a high sensitivity for cell tracking after systemic or in situ injection of cells having incorporated magnetic tags.
Indeed, using phagocytic cells, the detection of a single cell in mouse brain has been obtained with this technique [19] . This strategy spares laboratory animals and ultimately may be used for human stem cell inserm-00354437, version 1 -19 Jan 2009 therapy studies. Toward this end, new magnetic tracers readily and specifically taken up by stem cells need to be formulated. Superparamagnetic iron oxide (SPIO) nanoparticles stand as promising tools to label and track various cell types in vivo by MRI [6, 31, 43] . We developed SPIO nanoparticles coated with 1-hydroxyethylidene-1.1-bisphosphonic acid (HEDP) [38] , which are interesting due to their possible functionalization allowing the targeting and uptake of a specific cell type. In order to be able to translate this tool into the clinic, the innocuousness and the non-interference of these nanoparticles with the response of stem cells to their microenvironment have to be demonstrated.
In this study, we sought to characterize the potential effects of labeling rat MSC (rMSC) with these HEDP-coated SPIO nanoparticles on their viability and functions in vitro. Toward this end, rMSC iron uptake was characterized in vitro by Prussian blue (PB) staining and MRI. Iron-labeled rMSC viability and ultrastructure were also studied, as well as their osteogenic and neuronal differentiation potentials. Furthermore, we assessed the migratory potential of these iron-labeled MSC in vivo in response to the brain neurogenic stimuli. Indeed, it has been shown that neural stem cells (NSC) migrated from the subventricular zone (SVZ) to the olfactory bulb (OB), via the rostral migratory stream (RMS), where they differentiate into post-mitotic interneurons [11] . Therefore, we studied the ability of iron-labeled rMSC to migrate in a similar fashion than iron-labeled rat neural stem cells (rNSC), when transplanted into the SVZ of the lesioned or non-lesioned rat brain. This study was performed by bromodeoxyuridine (BrdU) immunohistochemistry (IHC) and PB staining. Finally, a double staining with PB/CD11b, specific for macrophage/microglia, was used to confirm the fate of the grafted cells and of the SPIO nanoparticles. inserm-00354437, version 1 -19 Jan 2009
RESULTS

Iron uptake and cell characterization
Prussian blue staining, after incubation of the rMSC with the iron-oxide nanoparticles, demonstrated that the intensity and the percentage of labeled cells increased with the iron concentration used. Forty eight hours incubation with an amount of nanoparticles corresponding to 25 µg iron/mL resulted in ca. 10 % of Prussian blue positive cells, 50 µg/mL efficiently labeled more than 90 % of the cells whereas 100 µg iron/mL did not increase the percentage of positive cells compared to 50 µg iron/mL ( fig. 1A , B, C respectively). For rNSC, PB staining revealed that 24 hours of incubation with 50 µg/mL iron gave the most efficient labeling ( fig. 1D ). rNSC were expanded as floating clusters called neurospheres but incubation in the iron containing medium was performed on adherent progenitors as the 3D structure of the neurospheres prevented an efficient labeling of all the cells.
Spectroscopic iron titration confirmed that the iron content per rMSC varied with the nanoparticle concentration used during labeling. Over the concentration range used (from 25 to 100 µg iron/mL), the intracellular concentration increased from ca. 3.5 pg/cell to 10 pg/cell (table 1). The differences in iron content per cell were also observed using in vitro MRI. Indeed, fig. 1E shows typical T2*-weighted images of an agarose gel containing iron-labeled rMSC. As the iron concentration increased in the incubation media, the T2* effects induced by the cells increased. Thus, cells incubated with 50 µg iron/mL induced a global T2* reduction of ca. 50% compared to unlabeled cells.
Trypan blue counting and MTS assay showed that cell viability was not affected one day postincubation when using 25 or 50 µg iron/mL, whereas it decreased to 70 % of control with 100 µg iron/mL. Consequently, 50 µg iron/mL incubated for 48 hours was chosen as the best trade-off in terms of iron content, percentage of marked cells and cell viability. It resulted in an average concentration of 5.6 ± 1.6 pg iron/cell as determined by spectroscopic iron titration (table 1). It should be noted that the facilitating Fugene® reagent was tested but did not significantly enhance iron uptake (data not shown).
It was consequently not used in this study.
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Under these conditions, iron-labeled cells did not exhibit morphological differences with unlabeled cells ( fig. 2A, B) . Moreover, transmission electron microscopy (TEM) demonstrated that ironlabeling did not affect rMSC ultrastructure and that the SPIO nanoparticles were taken into the cells rather than adhering to the exterior of the membrane. They were located in endo-lysosomial vesicles with a mean diameter of 355 nm ( fig. 2C) . Observations by scanning electron microscopy (SEM) confirmed the intracytoplasmic and perinuclear distribution of the nanoparticles. The small white dots observed on back-scattered SEM images ( fig. 2D ) were correlated to a difference in molecular composition and an energy dispersive x-ray (EDX) spectrum confirmed their iron nature ( fig. 2E ).
To confirm that iron-labeled rMSC maintain their function in vitro, differentiation studies were performed. Iron-labeled rMSC were still able to undergo an osteogenic differentiation. Moreover, a similar proportion of cells responded to this induction when compared to the control, unlabeled cells, as shown by Alizarin red staining of hydroxyapatite associated calcium mineral deposits ( fig. 3A, B) . In addition, rMSC developed features of neuronal cells in response to published protocols [49] . Most importantly, there was no significant difference between unlabeled and iron-labeled rMSC responses to the neuronal induction in vitro. Flat, uninduced rMSC expressed low levels of nestin and β3-tubulin 
In vivo detection of rNSC and rMSC
In the non-lesioned brain model, rMSC grafted into the SVZ did not respond to the stimuli of the neurogenic microenvironment and were only found in the grafting site ( fig. 5A ). Preliminary results indicated that, 5 days after grafting, rMSC close to the injection site stained positive for nestin as well as slightly for β3-tubulin (data not shown). We demonstrated that a mechanical lesion of the OB strongly 
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However, even though PB staining revealed a large number of iron-labeled rMSC in the lesioned OB region after the mechanical lesion ( fig. 5D ), this pool of migrating cells was not accessible to MRI as the lesion itself was responsible for a large hyposignal and labeled cells were only efficiently visualized at the grafting site ( fig. 6A, B) .
In non-lesioned rat brains, rNSC were found in the grafting site, in the RMS and in the OB 14 days after transplantation ( fig. 5F, G & table 3 ). Thus, iron-labeled rNSC migrated in a similar way than endogeneous rNSC in the absence of lesion. inserm-00354437, version 1 -19 Jan 2009
DISCUSSION
Potential adverse effects of iron nanoparticles is a topic currently under investigation [35] , and the means to diminish this side effect still remain to be explored. Many authors described the use of facilitating agents [2] such as lipofectamin [16] , conjugation with Tat peptide [26] or with internalizing antibodies [7] to increase the uptake efficiency while diminishing cell toxicity. However, these methods are also currently under debate [4] and transfecting agents may not be approved for clinical use [29] . In our study, we demonstrated an efficient and non toxic in vitro uptake of native HEDP-coated SPIO nanoparticles by rMSC without using any transfecting agent. In addition, the bisphosphonate (HEDP) coating offers the possibility to functionalize the nanoparticles, therefore increasing the range of potential applications.
Forty-eight hours incubation with 50 µg iron/mL of these SPIO nanoparticles was the best tradeoff in terms of labeling efficiency and cell viability. Under the conditions used, more than 90 % of the rMSC contained enough iron allowing their detection with PB staining; amount that is in the same range than what is usually described e.g. with D-mannose-coated nanoparticles where 80 % of the cells were labeled [43] . An efficient uptake is indeed required as a simple adhesion on the cell surface could be detrimental for the cell response to the microenvironment in vivo [43] . In this regard, we confirmed the endocytosis of the iron nanoparticles by SEM and TEM studies. In our study, the average iron content per cell (5.6 ± 1.6 pg) was low compared to what is described with polycation-bound SPIO nanoparticles (38 pg iron/cell) [43] , but in the same range to what is obtained when labeling human MSC with the ferucarbotran Resovist ® [29] .
In addition to an absence of acute toxicity, the HEDP-coated nanoparticles had no significant side effects on rMSC behavior in vitro. The ultrastructure was conserved and their differentiation potential toward the osteogenic as well as neuronal lineages did not exhibit significant differences with unlabeled rMSC. MSC differentiation toward a neuronal-like lineage is now well-documented [5, 39, 44, 46] and the fraction of differentiating rMSC (50 to 65 %) confirmed results published with this inserm-00354437, version 1 -19 Jan 2009
protocol [49] . Interestingly, NeuN was always detected in the rMSC used in this study. In this regard, the expression of neuronal markers in expanding, uninduced MSC has already been described [45] .
These results complement previous studies which described a conserved adipogenic and osteogenic differentiation potential [3, 14] even if chondrogenic differentiation was sometimes impaired with Feridex® nanoparticles [24] . Altogether, these results confirmed the possible use of the HEDP-coated nanoparticles for cell tracking as it does not seem to interfere with the in vitro rMSC biology. Moreover, trials made to label a subpopulation of human MSC, the MIAMI cells [12] showed that they readily absorbed HEDP-coated iron nanoparticles, even with a higher efficiency than rMSC (data not shown).
As MIAMI cells present a large differentiation potential, including the ectodermal lineage, this may render possible their future use for MRI tracking in human clinical cell therapy applications [44] .
In vivo, a double staining PB/CD11b (specific for macrophage/microglia) demonstrated that CD11b-positive cells did not, for the most part, co-localize with PB staining and therefore gave the proof that uptake by the host immune system is limited. Similar results with PB/ED1 double staining were obtained with rMSC containing dextran-coated Endorem® nanoparticles in a spinal cord injury model [41] . To our knowledge, this phenomenon has not been previously described in other cell types, suggesting that this event may be cell dependent. Therefore, the fate of iron nanoparticles will have to be addressed in more details in future studies using MSC. On the other hand, a possible transfer of BrdU to the host cells 3 weeks after transplantation has been described [8] , but as BrdU labeling co-localized nicely with PB in our study, it suggests that the majority of detected cells were iron-containing rMSC and not host cells.
Iron-labeled rMSC did not respond to the microenvironmental stimuli when stereotactically implanted into the SVZ and did not migrate toward the OB via the RMS. However, when transplanted in the SVZ of a rat brain presenting a mechanical injury of the OB, the iron-labeled rMSC extensively The fainter staining observed by IHC after 21 days may result from a possible cell proliferation, and therefore from an iron dilution, as was described for MSC transplanted in a brain infarct model 3 months after transplantation [50] . Using MRI, the fraction of rMSC migrating toward the OB was not detected as the mechanical lesion induced a very important background hyposignal. Therefore, precautions will have to be taken in studies seeking to visualize iron-labeled cells in similar lesioned environments. It is of importance to note that we did not observe any adverse effect on the behaviour of the animals even 21 days post-transplantation. Moreover, no signs of toxicity were detected by use of current histological staining (hematoxilin/eosin), therefore confirming the safety of SPIO nanoparticles for in vivo applications [33] .
Taken together, these in vivo results demonstrate that rMSC were not able to migrate in a similar fashion than rNSC when transplanted into the SVZ of a normal brain, but did confirm their known potential to be attracted by lesions, even after iron-loading [20, 42, 50] . It underlines the importance of the microenvironment on rMSC migratory behavior. Indeed, without lesion, in opposition to rMSC, neurosphere-derived iron-labeled rNSC, used as a positive control for cell migration, did respond to the SVZ niche stimuli and demonstrate an important migratory potential toward the OB through the RMS.
This confirmed previous studies using labeled rat NSC [10] , unlabeled NSC [13, 17] as well as labeled human NSC [18] . The migratory response of MSC to appropriate adhesion or inflammatory molecules and to chemokines present in damaged tissues is now well documented [36, 40] . Indeed, many chemoattractive molecules present in a lesioned environment, including for example the monocyte chemoattractant protein-1 (MCP-1), the macrophage inflammatory protein 1α (MIP-1α) and IL-8 [47] , are known to promote cell migration via an interaction with MSC cell surface receptors. Therefore, we assumed it was the underlying mechanism leading the migration of rMSC observed in the presence of an OB lesion. However, the migration in a normal adult brain of a MSC subpopulation expressing receptors known to regulate neural cell activity and migration in brain has been reported [37] . However, MSC are
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a heterogenous population so these receptors, including Neo1, Nrp2 and Robo1 & 4, may not be present on the rMSC used in this study as we did not observe any migration in an undamaged brain. Similarly to Phinney et al. [37] , we may hypothesize that MSC migrating in an inflammatory environment are a different subpopulation from those that migrate in response to guidance cues modulating neural cell migration.
As a conclusion, HEDP-coated SPIO nanoparticles were used to efficiently label rMSC without impairing cell viability and structure, as well as their differentiation potentials toward the osteogenic and neuronal lineages. In vivo, iron-labeled rMSC migration toward the OB was not induced by the SVZ microenvironment. However, their well-known capacity to migrate toward lesions was confirmed as they extensively migrated toward a mechanically injured OB. Moreover, a double staining for macrophage/microglia and iron-containing cells confirmed that the majority of detected cells were not host cells. To the best of our knowledge, this was the first time that a long distance migration from the SVZ toward a lesioned OB through the RMS was described for iron-labeled rMSC. This conserved ability to migrate in vivo when stimulated by a lesion, in addition to their differentiation potential, underlines once again the possible benefits of using mesenchymal stem cells for brain cell therapy. inserm-00354437, version 1 -19 Jan 2009
EXPERIMENTAL PROCEDURE
All animal experiments were conducted in accordance with the "Direction des Services 
Synthesis of HEDP-coated SPIO nanoparticles
SPIO nanoparticles were prepared and purified as previously described [38] . Briefly, bare iron cores were generated under agitation by the coprecipitation of an aqueous solution of 100 µL Magnetic relaxivities of those nanoparticles at 7 T were: r1=1 mM -1 s -1 and r2=50 mM -1 s -1 [32] .
Nanoparticle uptake and cell characterization
Iron labeling. Nanoparticles were added to the culture medium at a concentration of 25, 50 or 100 µg iron/mL for 24 or 48 hours after the rMSC reached 60 % confluency. Neuronal differentiation. Neuronal induction was performed according to a previously described protocol [49] . Briefly, rMSC were plated at 10x10 3 was set at -3.3 mm [48] . For some rats, an OB lesion was performed just after grafting the cells, ipsilaterally to the injection site at 6.5 mm from Bregma, using a 3 mm diameter drill.
In vivo immunohistochemical tracking
Four, 14 and 21 days after transplantation, rats were anesthetized by CO 2 inhalation. 0.9 % NaCl and 4 % PFA were used sequentially for intracardial perfusion and brains were left in PFA containing 
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For PB/CD11b double staining, sections were fixed again with 2 % PFA in DPBS for 5 min at 4°C after CD11b staining. Staining with Pearl's reagent was then performed as previously described and samples were examined by bright field microscopy.
In vivo MRI tracking
In vivo, MRI was performed under the conditions defined for in vitro study. A TE = 10 ms was chosen as it allowed to depict microscopic susceptibility inhomogeneities induced by SPIOs without jeopardizing the overall image quality by macroscopic susceptibility artefacts. During the in vivo imaging process, animals were anaesthetized using a mixture of isoflurane/O 2 (1.5 %, 2 L/min) and body temperature was maintained at 36.5-37.5°C using a feedback-regulated heating pad. 
